• Mon espace de travail
  • Aide IRIS
  • Par Publication Par Personne Par Unité
    • English
    • Français
  • Se connecter
Logo du site

IRIS | Système d’Information de la Recherche Institutionnelle

  • Accueil
  • Personnes
  • Publications
  • Unités
  • Périodiques
UNIL
  • English
  • Français
Se connecter
IRIS
  • Accueil
  • Personnes
  • Publications
  • Unités
  • Périodiques
  • Mon espace de travail
  • Aide IRIS

Parcourir IRIS

  • Par Publication
  • Par Personne
  • Par Unité
  1. Accueil
  2. IRIS
  3. Publication
  4. Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients.
 
  • Détails
Titre

Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients.

Type
article
Institution
UNIL/CHUV/Unisanté + institutions partenaires
Périodique
Journal of Hepatology  
Auteur(s)
Sarrazin, C.
Auteure/Auteur
Susser, S.
Auteure/Auteur
Doehring, A.
Auteure/Auteur
Lange, C.M.
Auteure/Auteur
Müller, T.
Auteure/Auteur
Schlecker, C.
Auteure/Auteur
Herrmann, E.
Auteure/Auteur
Lötsch, J.
Auteure/Auteur
Berg, T.
Auteure/Auteur
Liens vers les personnes
Noir, Isabelle  
Liens vers les unités
Gastro-entérologie  
ISSN
1600-0641
Statut éditorial
Publié
Date de publication
2011
Volume
54
Numéro
3
Première page
415
Dernière page/numéro d’article
421
Langue
anglais
Notes
Publication types: Journal Article ; Multicenter Study ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Résumé
BACKGROUND & AIMS: Genetic variation in the interleukin 28B (IL28B) gene has been associated with the response to interferon-alfa/ribavirin therapy in hepatitis C virus (HCV) genotype 1-infected patients. The importance of three IL28B single nucleotide polymorphisms (rs8099917, rs12980275 and rs12979860) for HCV genotype 2/3-infected patients is unknown.
METHODS: In patients with chronic hepatitis C genotype 2/3 (n=267), IL28B host genotypes (rs8099917, rs12980275 and rs12979860) were analyzed for associations with sustained virologic response (SVR) to antiviral therapy with (pegylated) interferon-alfa and ribavirin and with respect to epidemiological, biochemical, and virological parameters. For comparison, hepatitis C genotype 1 patients (n=378) and healthy controls (n=200) were included.
RESULTS: The rs12979860 CC genotype, lower age, and genotype 2 were significantly associated with SVR in HCV genotype 2/3-infected patients (p=0.01, p=0.03 and p=0.03, respectively). No association was observed for rs8099917 and rs12980275. In addition, an SVR in patients with rapid virologic response (RVR) was associated with the rs12979860 CC genotype (p=0.05), while for non-RVR no association was found. Furthermore, a significant association with a higher baseline viral load was observed for all three IL28B genotypes in genotype 1/2/3-infected patients. Finally, increasing frequencies of the rs12979860 CC genotypes were observed in genotype 1- (33.9%), genotype 3- (38.9%), and genotype 2-infected (51.9%) patients in comparison with healthy controls (49.0%) (p<0.01).
CONCLUSIONS: In genotype 2/3-infected patients, rs12979860 was significantly associated with SVR. The frequency of the rs12979860 CC genotype is lower in HCV genotype 1 vs. genotype 2/3 patients. All major IL28B genotypes are associated with HCV-RNA concentration.
Sujets

Adult

Alanine Transaminase/...

Alleles

Antiviral Agents/ther...

Base Sequence

Case-Control Studies

DNA Primers/genetics

Female

Gene Frequency

Genotype

Germany

Hepacivirus/classific...

Hepacivirus/drug effe...

Hepatitis C, Chronic/...

Hepatitis C, Chronic/...

Humans

Interferon Type I/the...

Interleukins/genetics...

Male

Middle Aged

Polymorphism, Single ...

RNA, Viral/blood

RNA, Viral/genetics

Recombinant Proteins

Ribavirin/therapeutic...

Viral Load

PID Serval
serval:BIB_7F67051E5415
DOI
10.1016/j.jhep.2010.07.041
PMID
21112657
WOS
WOS:000287562700005
Permalien
https://iris.unil.ch/handle/iris/176394
Date de création
2011-02-02T13:27:05.503Z
Date de création dans IRIS
2025-05-21T00:37:56Z
  • Copyright © 2024 UNIL
  • Informations légales